Product Information
PHENOBARBITAL 30 MG TABLET is a generic product labeled by e5 Pharma, LLC, priced at $0.1416 per EA under NDC 13517069201. Its NADAC has been published 191 times since Feb 8, 2023.
Strength
30 mg/1
Manufacturer
e5 Pharma, LLCNDC
13517069201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
11/30/2022
Price Statistics
The NADAC for PHENOBARBITAL 30 MG TABLET has been published 191 times since Feb 8, 2023, and over the history we have for it it has declined 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1416 per EA |
|---|---|
| All-time high | $0.2172 (Jul 12, 2023) |
| All-time low | $0.0913 (Nov 20, 2024) |
| 52-week high | $0.1674 |
| 52-week low | $0.1206 |
| Median price | $0.1538 |
| Average price | $0.1522 |
| Largest weekly change | -45.1% (Nov 20, 2024) |
| Weeks tracked | 191 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the phenobarbital market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
e5 Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
phenobarbital market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 30 MG TABLET, manufactured by e5 Pharma, LLC, is $0.1416 per EA (NDC 13517069201), effective Sep 30, 2026.
How has the price of PHENOBARBITAL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 30 MG TABLET has declined 26.1%. It has been tracked across 191 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 30 MG TABLET?
Since Feb 8, 2023, the NADAC for PHENOBARBITAL 30 MG TABLET has ranged from a low of $0.0913 (Nov 20, 2024) to a high of $0.2172 (Jul 12, 2023), with a median of $0.1538 per EA.
Are there cheaper alternatives to PHENOBARBITAL 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PHENOBARBITAL 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PHENOBARBITAL 30 MG TABLET?
PHENOBARBITAL 30 MG TABLET (NDC 13517069201) is labeled by e5 Pharma, LLC, and CMS classifies it as a generic product.